Article Details

Deregulating Psychedelics To Propel Clinical Research - Technology Networks

Retrieved on: 2024-04-29 01:05:25

Tags for this article:

Click the tags to see associated articles and topics

Deregulating Psychedelics To Propel Clinical Research - Technology Networks. View article details on hiswai:

Summary

The article, written by Callaghan, Geerts, and Loebs, advocates for the therapeutic potential of psychedelics like psilocybin and MDMA in enhancing neuroplasticity to treat mental health disorders, amidst legislative shifts toward deregulation for medical research.

Article found on: www.technologynetworks.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up